HIGHLIGHTS
- who: Low-Dose Cisplatin Promotes and colleagues from the Department of Respiratory and Critical Care Medicine, The Second Affiliated Hospital of Chongqing Medical University, Chongqing, China have published the research work: CNTN-1 Upregulation Induced by Low-Dose Cisplatin Promotes Malignant Progression of Lung Adenocarcinoma Cells via Activation of Epithelial-Mesenchymal Transition, in the Journal: (JOURNAL)
- what: In this study, wound-healing assay and invasion assay were conducted to examine cell migration and invasion and the data displayed that both migration cisplatin were increased compared with that of controls.
- how: Showed that A549 . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.